Illinois Senate passed the Equal Rights Amendment
On April 11, 2018 the Illinois Senate passed the Equal Rights Amendment as Senate Joint Resolution Constitution Amendment 4 (SJRCA4). The fight now goes to the House.
While we are disappointed with all 43 Senators who voted for abortion, we are gravely disturbed by those who solicited pro-life support and presented themselves as pro-life but voted for the ERA. Their vote was a vote in opposition to life and will not be ignored. The Illinois Federation for Right to Life PAC, Illinois Citizens for Life PAC, Illinois Family Action PAC, Illinois Family PAC, and Lake County Life PAC will not endorse or support any legislator that casts a vote for such a sweeping pro-abortion piece of legislation as the ERA. Click here for more
March 30, 2016
FDA expansion of abortion pill use still does not necessarily mean chemical abortion is safer
The FDA, responding to a request by the U.S. distributor of the drug, has modified dosages, changed the administration, reduced the number of visits, expanded the prescriber pool, and extended the time frame where the drugs may be used. Though applauded by the abortion industry, the documentation demonstrating the impact on women’s safety has not been made publicly available.
Certainly, none of the modifications is of any benefit to the unborn child.
For women, the mifepristone/misoprostol combination comes with significant cramping, bleeding, and other gastrointestinal side effects (nausea, vomiting, diarrhea) that are expected parts of the chemical abortion process.
While it may be claimed that these side effects are supposed to be reduced with the new protocol, chemical abortions simply do not occur without significant bleeding, cramping, etc. That these side effects are similar to signs of ruptured ectopic pregnancy, serious infection, or may be the prelude to significant hemorrhage that could be missed by patients or even doctors expecting these as part of any chemical abortion would still appear to be a problem under any protocol.
In the end, it is obvious that the FDA’s new protocol serves only the interests of the abortion industry by expanding their base of potential customers, increasing their profit margin, and reducing the level of staff and amount of resources they have to devote to the patient.
Click here for more from National Right to Life.